Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular proteins containing cysteine thiol groups represent a broad class of biological molecules where the sulfur-containing side chain of cysteine serves as a critical functional site. These thiol (-SH) groups are essential for maintaining protein tertiary structure via disulfide bond formation and act as nucleophilic centers in the catalytic sites of various enzymes, including cysteine proteases and phosphatases (Source: Nature Reviews Molecular Cell Biology, 2018). In therapeutic contexts, these groups are targeted by covalent inhibitors, such as Ibrutinib and Afatinib, which form irreversible bonds with specific cysteine residues to achieve prolonged target engagement and high potency (Source: Nature Reviews Drug Discovery, 2011). Beyond targeted therapy, protein thiols are central to cellular redox homeostasis, acting as sensors for oxidative stress and targets for reactive oxygen species (Source: Antioxidants & Redox Signaling, 2013). However, the high reactivity of these groups poses significant challenges, as non-specific modification can lead to off-target toxicity, immunogenicity through hapten formation, and the depletion of essential cellular antioxidants like glutathione (Source: Chemical Research in Toxicology, 2016). This category encompasses a vast array of proteins rather than a single therapeutic entity, making specificity a primary concern in drug development.
Drugs targeting cellular cysteine thiols typically function through covalent modification, where an electrophilic moiety on the drug (e.g., an acrylamide group) reacts with the nucleophilic sulfur atom to form a stable, irreversible bond (Source: Journal of Medicinal Chemistry, 2015). Other mechanisms include redox modulation, where agents like N-acetylcysteine provide exogenous thiol groups to restore redox balance, or chelation, where drugs like dimercaprol bind to metal ions that have coordinated with protein thiols to facilitate their removal (Source: StatPearls, 2023).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular proteins containing cysteine thiol groups (Protein thiols).